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Abstract: The GLUT members belong to a family of glucose transporter proteins that facilitate glucose
transport across the cell membrane. The mammalian GLUT family consists of thirteen members
(GLUTs 1–12 and H+ -myo-inositol transporter (HMIT)). Humans have a recently duplicated GLUT
member, GLUT14. Avians express the majority of GLUT members. The arrangement of multiple
GLUTs across all somatic tissues signifies the important role of glucose across all organisms. Defects
in glucose transport have been linked to metabolic disorders, insulin resistance and diabetes. Despite
the essential importance of these transporters, our knowledge regarding GLUT members in avians
is fragmented. It is clear that there are no chicken orthologs of mammalian GLUT4 and GLUT7.
Our examination of GLUT members in the chicken revealed that some chicken GLUT members do not
have corresponding orthologs in mammals. We review the information regarding GLUT orthologs
and their function and expression in mammals and birds, with emphasis on chickens and humans.
Keywords: glucose transporter; GLUTs; chicken; avian; mammal; phylogenetic analysis

1. Introduction
The GLUTs are a family of glucose transporter proteins that transport glucose bidirectionally
across cell membranes by way of facilitative diffusion [1,2]. They are members of the solute carrier
family 2A (slc2a). GLUTs are composed of 12 membrane-spanning helices with regions in the
extracellular matrix and cytoplasm and contain several functionally conserved motifs [3,4]. In humans,
the GLUT family consists of GLUTs 1–12 and H+ -myo-inositol transporter (HMIT). HMIT is also known
as GLUT13 [5]. Humans also have additional expression of GLUT14, which is a duplicon of GLUT3 [6].
Based on phylogenetic analyses, GLUTs are divided into three classes. Class I is made up of GLUTs
1–4, and GLUT14 in humans. Class II consists of GLUTs 5, 7, 9 and 11. Class III contains GLUTs 6, 8,
10, 12 and HMIT/GLUT13 [5]. It is widely believed that all members of the GLUT family originated
from a common ancestor through duplication. During evolution, duplicated members acquired
specialty such that they may either develop substrate specificity, or could be regulated in specialized
ways that are advantageous to the species. In cells, multiple GLUTs are arranged in a tissue-specific
manner, exhibiting different kinetic and regulatory properties [5,7]. All ectopically expressed GLUT
members have demonstrated the ability to facilitate hexose transport [5], while some are specific to the
transport of urate, myo-inositol or fructose. Fructose transport is especially important due to metabolic
abnormalities acquired from high concentrations of fructose in the diet [8]. Defects in glucose and
fructose transport are associated with insulin resistance, diabetes [9] and hyperfructosemia [10].
GLUT expression patterns are complex features. Much attention has been focused on
characterizing mammalian GLUT members and elucidating their specific physiological roles. Several
studies have also examined the role of GLUTs among avian species, which have provided a basis for
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understanding GLUT expression patterns in various tissues during different stages of development.
However, due to the underlying complex nature of GLUTs, despite the progress made in GLUT
research, our knowledge about avian GLUTs is fragmented. For example, the exact physiological role is
still not clear for several GLUTs, and even the tissue specificity of GLUTs is not fully examined. In this
article, we review what is known about facilitative GLUT family members and their function and
expression in birds, with particular emphasis on chickens, and the mammalian (especially human’s)
GLUTs as a starting point for a better understanding.
2. Glucose Transport
After the breakdown of dietary polysaccharides, glucose, fructose and galactose are taken up
by enterocytes lining the microvilli of the small intestine. GLUT5 on the lumenal surface of the
small intestine mediates fructose uptake. Sodium-dependent glucose cotransporters (members of the
sodium-glucose cotransporter (SGLT) protein family) mediate the uptake of glucose and galactose.
GLUT2 on the basolateral surface of enterocytes facilitates the release of hexoses into the circulatory
system for reuptake by other cells [11]. When monosaccharide levels are high, GLUT2 may facilitate
hexose uptake from the gut lumen [12]. In hepatocytes and other somatic cells, GLUT5 mediates
fructose uptake from the circulatory system. Phosphorylation by tissue-specific kinases converts
cytosolic glucose to glucose-6-phosphate (G6P). The negative charge on G6P prevents it from crossing
the cell membrane. Glucokinase, which has a low affinity for glucose and is not inhibited by G6P,
catalyzes this reaction in hepatocytes. When blood glucose concentrations are high, hepatocytes
may accumulate G6P to buffer glucose concentrations. Glucose-6-phosphatase allows G6P from
gluconeogenesis and glycogen breakdown to exit liver and kidney cells. Hexokinase isoforms,
which have a high affinity for glucose and are feedback inhibited by G6P, catalyze the reaction
of glucose to G6P in other body tissues. Those tissues can take up glucose during times when
blood glucose concentrations are low. However, they are not able to accumulate high levels of G6P.
The absence of glucose-6-phosphatase makes glucose uptake irreversible in those tissues [13,14].
3. GLUT Transporter Classes
3.1. Class I GLUTs
GLUTs 1–4, and GLUT14 in human, make up the Class I family of glucose transporters.
In mammalian species, the glut1/slc2a1 gene encodes the major GLUT protein of the blood–brain
barrier [15]. The encoded protein is located primarily along the cell surface and in the cell membrane.
GLUT1 may be responsible for constitutive or basal glucose uptake in cells and can transport a
wide range of aldoses, including pentose and hexose [16,17]. On the cell surface, human GLUT1
may function as a receptor for T-cell leukemia virus I and II. Gene mutations associated with
GLUT1 deficiency in humans have been linked to microcephaly and childhood epilepsy [18,19],
hypoglycorrhachia [20,21], cryohydrocytosis with reduced stomatin [22], paroxysmal dystonic
choreathetosis [23], episodic ataxia [22], hemiplegic migraines [24,25], spasticity and paroxysmal
exertion-induced dyskinesia [26]. Overexpression of GLUT1 was shown to be an indicator for
cancer [27] and to have an association with thymic carcinoma [28]. Suppression of GLUT1 by apigenin
slowed overexpression of GLUT1 and had anticancer properties in mouse lung cancer cells [29].
Chicken GLUT1 shares 80% amino acid residues with humans [30]. Chicken GLUT1 has ubiquitous
expression, with abundant expression in the hypothalamus, and has demonstrated response to insulin
and dexamethasone [31]. According to the National Center for Biotechnology Information (NCBI)
Gene Database [32], glut1/slc2a1 orthologs are conserved in 124 organisms including human, chicken,
chimpanzee, cow, mouse, rat, Rhesus monkey, zebrafish and Eremothecium gossypii (fungus).
In mammals, glut2/slc2a2 encodes a glycoprotein. The encoded protein regulates bidirectional
glucose transport across liver cells, pancreatic islet beta cells that store and release insulin, epithelial
kidney cells and intestines. Similar to mammalian species, chickens have abundant GLUT2 expression
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in the liver [33], pancreatic beta cells, kidney and small intestine [34]. Due to its low affinity for glucose,
GLUT2 may be a glucose sensor. glut2/slc2a2 gene mutations in humans are associated with increased
disease susceptibility, including noninsulin-dependent diabetes mellitus and Fanconi–Bickel syndrome.
Mutations in glut2/slc2a2 were also found to increase risk of cardiovascular disease in patients with
type 2 diabetes [35,36]. Alternative gene splicing results in multiple transcript variants. Based on
the NCBI Gene Database [32,37], glut2/slc2a2 orthologs have been found in 168 organisms including
human, chicken, dog, chimpanzee, cow, Rhesus monkey, rat, Xenopus tropicalis (western clawed frog),
Xenopus laevis (African clawed frog) and zebrafish.
Mammalian GLUT3 facilitates the uptake of glucose, 2-deoxyglucose, galactose, mannose, xylose,
fucose and other monosaccharides across the cell membrane. GLUT3 does not mediate fructose
transport [36,38]. GLUT3 deficiency has been implicated in age of onset in Huntington’s disease [39].
Chicken GLUT3 is known to be a neuronal glucose transporter and shares 70% sequence similarity
with that of humans [2]. The neuronal functions of GLUT1 and GLUT3 are similar across chickens
and mammals [30,31]. In chickens, the upregulation of GLUT1 and GLUT3 is associated with the
formation of tight junctions in the blood-retinal barrier [40]. Orthologs of glut3/slc2a3 are preserved
across 70 organisms so far, including chicken, dog, cow, chimpanzee, mouse, rat, Rhesus monkey,
X. tropicalis, X. laevis, zebrafish, fruit fly, mosquito, Caenorhabditis elegans (non-parasitic roundworm),
Saccharomyces cerevisiae (yeast), Kluyveromyces lactis (yeast), rice, Magnaporthe oryzae (rice blast fungus),
Neurosporra crassa (red bread mold) and Arabidopsis thaliana (flowering plant), according to the NCBI
Gene Database [32,37].
It is well known that GLUT4 is the major insulin sensitive glucose transporter in mammals.
The mechanism by which insulin regulates GLUT4 activity has been well studied. Upon stimulation
by insulin, intracellular GLUT4 translocates to the plasma membrane, where GLUT4 facilitates cellular
glucose uptake. This constitutes the major portion of insulin-stimulated glucose uptake, especially
in adipose tissue, skeletal muscle and cardiac muscle tissues. Humans and most mammals rely on
normal protein expression of GLUT4 for blood glucose homeostasis [41]. glut4 gene mutations in
humans are associated with type 2 diabetes mellitus [42]. According to the NCBI Gene Database,
glut4/slc2a4 orthologs are found in 114 organisms including dog, cow, chimpanzee, mouse, rat and
Rhesus monkey [32,37]. Chickens intrinsically lack glut4 expression, and chickens are known to be
naturally hyperglycemic with adipose tissue [2,43,44] and skeletal muscle tissue [45] that is poorly
sensitive to insulin.
GLUT14, a duplicon of GLUT3, has been shown to have messenger RNA (mRNA) expression
in the human testis [6] and, according to the NCBI Gene Database, may have a specific function
related to spermatogenesis in males [46]. One study linked a polymorphism of slc2a14 to having a
possible role in the development of late-onset Alzheimer’s disease in a Han Chinese population [47].
High GLUT14 expression was also found to be associated with gastric adenocarcinoma [48]. According
to the NCBI Gene Database, slc2a14 orthologs are present in humans and Western gorillas [32,37].
In Oryctolagus cuniculus (rabbit), slc2a14 is known as proteins GLUT3 and SLC2A14. In Rhesus monkey,
the LOC715795 gene is known as proteins SLC2A3 and SLC2A14. slc2a3b orthologs are also present in
zebrafish. UniProt lists slc2a1 as the gene that encodes the GLUT14 protein in X. tropicalis, inferred
from database entries.
3.2. Class II GLUTs
Class II consists of GLUTs 5, 7, 9 and 11. GLUT5 is a fructose transporter protein with expression
across many species [49]. According to the NCBI Gene and Protein databanks, human GLUT5
is thought to be a cytochalasin β-sensitive carrier with expression in human testis, spermatozoa,
small intestine [49], adipose tissue and skeletal muscle [50]. More recent RNA-seq analyses found
human GLUT5 expression in duodenum, bone marrow and kidney [51]. GLUT5 was found to
have an association with malignant clear renal cell carcinoma [52]. According to the NCBI Gene
database [32,37], orthologs of glut5/slc2a5 are found so far in 123 organisms across chicken, dog, cow,
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chimpanzee, Rhesus monkey, mouse, rat and X. tropicalis. Chicken GLUT5 has been shown to have
mRNA expression in the small intestine [53] and may be regulated by glucocorticoids [54].
GLUT7 has been identified as a high affinity transporter for glucose and fructose. GLUT7 does
not transport galactose, 2-deoxyglucose or xylose [55]. Human GLUT7 has expression in the small
intestine and colon, with lower expression levels in the testis and prostate [55]. Based on our searches
of the NCBI Gene and Protein Database and UniProt Database [37,46,56], there are no data for GLUT7
in chickens or other avian species, suggesting that the avian lineage has lost slc2a7 during evolution.
Orthologs of slc2a7 are conserved in 55 organisms across mouse, rat, chimpanzee and Rhesus monkey,
according to the NCBI Gene Database.
GLUT9 is a known transporter of fructose and urate and can transport glucose at a low rate.
Mammalian GLUT9 plays a regulatory role in the development and survival of cartilage chondrocytes
and may have a role in urate reabsorption by proximal tubules [57,58]. One study linked gout to GLUT9
deficiency in a population of Japanese males [59]. It is assumed that chicken GLUT9 mediates uric
acid uptake, although substrate specificity for this GLUT transporter has not yet been identified [33].
Liver mRNA expression of GLUT9 was shown to be greater in obese chickens, possibly due to having a
larger glucose uptake capacity with greater demand and glucose load in high bodyweight chickens [33].
Based on the NCBI Gene Database [32,37], two transcript variants with distinct isoforms have been
identified for glut9/slc2a9. Orthologs of glut9/slc2a9 are present in 153 organisms including chicken,
dog, cow, mouse, rat, chimpanzee, X. tropicalis and X. laevis.
According to the NCBI Gene Database, GLUT11 is also known as GLUT10. GLUT11 is a
transporter of glucose and fructose, but does not transport galactose in humans. GLUT11 has
roughly 42% amino acid sequence similarity to GLUT5 and 35% similarity to GLUT1 [60]. Alternative
splicing results in multiple transcript variants, including GLUT11-A, GLUT11-B and GLUT11-C [61].
Mammalian GLUT11-A has expression in skeletal muscle, heart and kidney. Mammalian GLUT11-B is
expressed in adipose tissue, kidney and placenta. Mammalian GLUT11-C has expression in skeletal
muscle, heart, adipose tissue and pancreas [62]. Based on NCBI RefSeq, there is also evidence of a
fourth GLUT11 isoform, known as GLUT11-D [46]. Human glut11/slc2a11 orthologs are present in
111 organisms and conserved across chicken, dog, cow, chimpanzee, Rhesus monkey, zebrafish and
X. tropicalis, based on the NCBI Gene Database [37]. Rats and mice lack the glut11/slc2a11 gene [62].
3.3. Class III GLUTs
Class III contains GLUTs 6, 8, 10, 12 and HMIT/GLUT13. According to NCBI, slc2a6 has alias
GLUT6 and GLUT9 proteins in humans, mice and X. tropicalis. GLUT6 is a hexose transporter
protein. Mammalian GLUT6 is highly expressed in the brain, spleen and leukocytes [63]. One study
linked an upregulation of GLUT6 to endometrial cancer in women [64]. Based on the NCBI Gene
Database [32,37], GLUT6/SLC2A6 orthologs are present in 169 organisms including chicken, dog, cow,
mouse, chimpanzee, Rhesus monkey, zebrafish, fruit fly, mosquito, X. tropicalis and X. laevis.
Based on sequence similarity, GLUT8 has been identified as an insulin-regulated glucose
transporter. According to NCBI, GLUT8 binds cytochalasin β in a glucose-inhibitable manner.
Mammalian GLUT8 may be dual-specific and is inhibitable by fructose. A recent study on the
mouse atria suggests that GLUT8 has a role in glucose uptake in the mammalian heart, along with
GLUT4 [65]. glut8/slc2a8 orthologs are conserved across 171 organisms including chicken, dog, mouse,
rat, cow, chimpanzee, Rhesus monkey, X. tropicalis, zebrafish, fruit fly, A. thaliana and rice, according to
NCBI. Similar to mammals, chicken GLUT8 is a known insulin-responsive glucose transporter with
ubiquitous expression in cells and higher mRNA concentrations in adipose tissue and kidney [1].
According to the NCBI Gene Database, GLUT10 plays a role in glucose homeostasis regulation.
Human GLUT10 has highest mRNA expression in the liver and pancreas [66]. In humans, genetic
mutations of glut10/slc2a10 are associated with arterial tortuosity syndrome, a rare connective tissue
disorder [67]. Based on NCBI, glut10/slc2a10 orthologs are conserved across 166 organisms including
chicken, dog, mouse, rat, chimpanzee, Rhesus monkey, cow, X. tropicalis, X. laevis and zebrafish [32,37].
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According to the Gene Database at NCBI, the slc2a12 encoded protein contains alias GLUT8 and
GLUT12 in humans. GLUT12 can facilitate transport of a variety of hexoses [68]. Human GLUT12 is
expressed in skeletal muscle, heart and prostate, with lower mRNA expression in the brain, placenta
and kidneys [69]. A recent study implicated GLUT12 expression in the frontal cortex for its role
in Alzheimer’s disease, a metabolic disease which impairs the brain’s ability to utilize glucose [70].
The GLUT12 level, as well as GLUT1 level, was shown to be elevated in hypertension and diabetic
neuropathy in animal studies [71]. A recent study of GLUT12 in chicken skeletal and cardiac muscle
suggests that GLUT12 may act as an insulin-sensitive transporter similar to GLUT4 in mammalian
species [72]. Orthologs of glut12/slc2a12 are conserved across 177 organisms including chicken, dog,
mouse, rat, chimpanzee, Rhesus monkey, cow, X. tropicalis, X. laevis, zebrafish, A. thaliana and rice,
based on the NCBI Gene Database [32,37].
Studies on Xenopus oocytes have helped identify GLUT13 as a proton (H+ ) myo-inositol
cotransporter with specificity for the transport of myo-inositol, inositol triphosphate and related
stereoisomers [73,74]. Mammalian HMIT/GLUT13 is predominantly expressed in glial cells and some
neurons and may be responsible for myo-inositol brain metabolism regulation [73]. Intracellular
function of HMIT may also be responsible for mood control [74]. Genetic alterations of HMIT may
also be associated with non-small-cell lung cancer [75] and Parkinson’s disease [76]. According to the
NCBI Gene Database [32,37], glut13/slc2a13 orthologs are conserved across 151 organisms including
chicken, dog, cow, chimpanzee, Rhesus monkey, mouse, rat, X. tropicalis, X. laevis, zebrafish, C. elegans,
S. cerevisiae, K. lactis, E. gossypii, Schizosaccharomyces pombe (fission yeast), A. thaliana and rice.
4. GLUT Annotation
Automated computational analysis using genomic sequencing prediction method and contig
reference sequencing has assisted in identifying glut/slc2a genes across different species. Through these
methods, avian species Struthio camelus australis and Anas platyrhynchos have been shown to contain
orthologs of gluts 1, 2, 3, 5, 6, 8, 9, 10, 11, 12 and hmit/glut13. The turkey (Meleagris gallopavo) contains
gluts 1, 2, 5, 6, 8, 9, 10, 12 and hmit/glut13, but glut3 and glut11 have not yet been identified in turkey.
From UniProt analysis, the duckbill mammal platypus (Ornithorhynchus anatinus) contains glut members
1, 2, 3, 4, 6, 8, 9, 10, 11, 12 and hmit/glut13. However, these GLUT proteins remain uncharacterized in the
species. From our analysis, glut5 or glut7 genes have not been identified in platypus.
It is not surprising that some GLUT members are annotated confusingly in public databases.
Table 1 shows alias GLUT members GLUT6 and GLUT9, GLUT11 and GLUT10 and GLUT12 and
GLUT8. The Gene Database at NCBI annotated slc2a6 encoded protein as alias proteins GLUT6 and
GLUT9 in human, mouse and X. tropicalis. Human slc2a11 encoded protein was annotated as alias
proteins GLUT10 and GLUT11. Clearly, slc2a6 and slc2a9 in human, mouse and X. tropicalis are discrete
genes that encode discrete GLUT proteins; slc2a10 and slc2a11 in human are discrete genes which
encode discrete GLUT proteins; and slc2a8 and slc2a12 in human are also discrete genes which encode
discrete GLUT proteins.
Table 1. Alias glucose transporter (GLUT) members.
Gene

Alias

slc2a6
slc2a9
slc2a6
slc2a9
slc2a6
slc2a9
slc2a10
slc2a11
slc2a8
slc2a12

6, 9
6, 9
6, 9

10, 11
8, 12

Accession
Number

Species

Chromosome

Exons

A.A.

Start

End

Span

NP_060055.2
NP_064425.2
AAI41169.1
AAI38214.1
XP_017945590.1
XP_017950705.1
NP_110404.1
NP_110434.3
NP_055395.2
EAW47994.1

Human
Human
Mouse
Mouse
X. tropicalis
X. tropicalis
Human
Human
Human
Human

9
4
2
5
Unknown
1
20
15
9
6

11
24
10
20
10
15
8
14
11
7

507
540
443
523
504
527
541
503
477
617

133,472,024
9,826,400
27,021,917
38,351,086
95,667
195,610,477
5,931,524
8,026,649
127,397,231
133,991,158

133,479,059
10,021,429
27,027,905
38,483,364
104,372
195,628,747
5,933,981
8,027,108
127,407,246
134,052,480

7036
195,030
5989
132,279
8706
18,271
2458
460
10,016
61,323
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5. Evolutionary Relationships among GLUT Members
Figure 1 presents a timetree, which was constructed with Molecular Evolutionary Genetics
Analysis Version 6.0 (MEGA6) software [77], for GLUT members from human, mouse, chicken,
turkey (Melga) and X. tropicalis. The tree was calibrated with GLUT12, assuming the time of separation
between mammals and birds was 300 million years. The human GLUT11-A was included in the
phylogenetic analysis. This analysis was conducted using the Neighbor–Joining bootstrap method
with 50 replicates. Topological branching point divergence times were calculated with maximum
likelihood based on the Jones–Taylor–Thornton matrix-based method and are based on units of the
number of amino acid substitutions per site.
GLUT amino acid sequences were downloaded from UniProt or NCBI and derived from evidence
at the transcript level, protein level or homology. Dataset for the timetree contained 63 amino acid
sequences with a total of 426 positions included in the final dataset. Positions with fewer than 95%
site coverage were eliminated. Less than 5% alignment gaps, missing data and ambiguous bases were
allowed at any position. The timetree is drawn to scale with the relative number of substitutions
per site.
According to this timetree, Class III GLUTs separated from Class I and Class II approximately
2000 million years ago. Class I and Class II GLUTs separated about 1700 million years ago, around the
time when multicellular life began. GLUTs 1 and 3 separated approximately 800 million years ago.
Evidently, GLUT13/HMIT orthologs could not be resolved well with this tree construction method,
which can be seen from the distance between mammals and birds being not reflecting the species tree.
GLUT8 and GLUT10 orthologs had the least constraints among the GLUT family members.
Based on the phylogenetic analysis as well as the result of experiments conducted in our laboratory,
we have recognized that accession number gg5L_X1_XP_426528.4, which is annotated as GLUT
member 5-like isoform X1 in chickens, is a gene product that is separate from the true GLUT5 member
of chicken and other species and has more similarity to the GLUT9. Several GLUT11-like members
were also found in chickens, each of them being the product of a discrete gene (Figure 1).
6. Chicken GLUT Members
Characteristics of human and chicken GLUT members are summarized in Table 2. The first
chicken genome draft has helped to identify genes for GLUTs 1, 2, 3, 5, 8 and 9 in chicken [78]. GLUT12
was also recently examined in chicken skeletal and cardiac muscle [72]. For chicken studies, GLUT1 has
been analyzed across various chicken tissues [33] and embryonic myoblasts [31] and fibroblasts [79].
glut2 was cloned by screening a chicken liver cDNA library [34] and examined for expression in
various chicken tissues [1,57]. GLUT3 was examined across various chicken tissues [1,30,33]. GLUT5
was examined for its presence in enterocytes and its mRNA expression pattern [55,57]. GLUT8 has
been tested across various chicken tissues [1,2]. GLUT9 was tested in chickens [33]. GLUTs 6, 9, 10,
11, 12 and HMIT/GLUT13 were derived from orthology from a 2004 large-scale analysis comparing
evolutionary conserved regions between chicken and mammalian genomes [78], but little information
is available regarding their expression patterns.
GLUT expression patterns vary across species, and glucose transport may be regulated by different
factors in those species. One such example is GLUT4, which is required for normal cellular metabolism
in mammalian species, but is lacking in avian species.
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Figure 1. Evolutionary relationships of GLUTs. This evolutionary timetree was conducted in MEGA6

Figure 1. Evolutionary relationships of GLUTs. This evolutionary timetree was conducted in MEGA6
using the Neighbor–Joining bootstrap method. Each node represents a 95% confidence interval.
using theAnalysis
Neighbor–Joining
bootstrap method. Each node represents a 95% confidence interval.
included 63 GLUT amino acid sequences with a total of 426 positions in the final dataset.
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(Meleagris gallopavo).
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Table 2. Characteristics of human and chicken GLUT members.
Gene

Orthologs

Human

Chicken

Conserved in human, chicken,
chimpanzee, cow, mouse, rat,
Rhesus monkey, zebrafish,
Eremothecium gossypii.
122 organisms contain
orthologs with slc2a1 [46].

Blood-brain barrier [15]. Receptor for
T-cell leukemia virus I and II [46].
Microcephaly, childhood epilepsy [18,19],
hypoglycorrhachia [20,21],
cryohydrocytosis [22], choreathetosis [23],
ataxia [22], migraines [24,25], spasticity,
dyskinesia [26], indicator for cancer [27],
thymic carcinoma [28].

Hypothalamus, basal
glucose uptake,
ubiquitous [31,34].

glut2/slc2a2

Conserved in human, chicken,
dog, chimpanzee, cow, Rhesus
monkey, rat, frog and
zebrafish. 168 organisms have
orthologs of slc2a2 [46].

Glycoprotein, bidirectional transport in
liver, islet beta cells, intestine, kidney,
glucose sensor, gene mutations associated
with susceptibility to disease,
noninsulin-dependent diabetes,
Fanconi–Bickel syndrome. Alternative
splicing results in multiple transcript
variants of this gene [33,34].

Fructose, galactose, liver,
pancreas, small intestine,
kidneys [1,33,57], insulin
dependent [33].

glut3/slc2a3

Conserved in dog, cow, frog,
chimpanzee, Rhesus monkey,
mouse, rat, chicken, zebrafish,
fruit fly, mosquito,
Caenorhabditis elegans,
Saccharomyces cerevisiae,
Kluyveromyces lactis,
Magnaporthe oryzae,
Neurosporra crassa, Arabidopsis
thaliana and rice. 70 organisms
have orthologs of slc2a3 [46]

Mediates uptake of glucose,
2-deoxyglucose, galactose, mannose,
xylose, fucose and other monosaccharides
across the cell membrane. Gene mutation
associated with Huntington’s disease
[39,40] .

Neurons [1,30],
insulin dependent [33].

glut4/slc2a4

Conserved in chimpanzee,
Rhesus monkey, dog, cow,
mouse and rat. 114 organisms
have orthologs of slc2a4 [46].

Insulin-regulated. Upon insulin
stimulation, GLUT4 translocates to cell
surface to transport glucose across the cell
membrane. Gene mutations are
associated with noninsulin-dependent
diabetes mellitus [41].

Not exist in
chickens [2,80].

glut5/slc2a5

Conserved in chicken, dog,
mouse, rat, chimpanzee,
Rhesus monkey, cow and frog.
123 organisms have orthologs
of slc2a5 [46].

Thought to be cytochalasin β-sensitive
carrier, expression in small intestine [49],
adipose tissue, skeletal muscle [50],
duodenum, bone marrow, kidney [51],
renal cell carcinoma [52].

Fructose, small
intestine [55,57].

glut6/slc2a6

Conserved in chicken, dog,
cow, chimpanzee, mouse,
Rhesus monkey, zebrafish,
fruit fly, mosquito and frog.
169 organisms have orthologs
of slc2a6 [46].

GLUT6/GLUT9 [46],
hexose transport [63],
endometrial cancer [64].

Uncharacterized
protein [78].

glut7/slc2a7

Conserved in mouse, rat,
chimpanzee and Rhesus
monkey. Orthologs found in
55 organisms [46].

Glucose, fructose transport, expression in
small intestine and colon, lower levels in
testis and prostate [55].

Not found in chickens.

glut8/slc2a8

Conserved in chicken, dog,
mouse, rat, chimpanzee,
Rhesus monkey, cow,
zebrafish, fruit fly, rice,
A. thaliana and frog. Orthologs
found in156 organisms [46].

Insulin-regulated, binds cytochalasin β in
glucose-inhibitable manner, may be
dual-specific, as it is inhibitable by
fructose [69].

Ubiquitous, especially in
adipose tissue, kidneys,
insulin response [1,2].

glut9/slc2a9

Conserved in chicken, dog,
cow, chimpanzee, mouse, rat
and frog. Orthologs found in
153 organisms [46].

Fructose, urate transport, and glucose at a
low rate, urate reabsorption by proximal
tubules, regulatory role in development
and survival of chondrocytes [59].

Liver [33].

glut1/slc2a1
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Table 2. Cont.
Gene

Human

Chicken

Conserved in chicken, dog,
mouse, rat, chimpanzee,
glut10/slc2a10 Rhesus monkey, cow, frog and
zebrafish. Orthologs found in
166 organisms [46].

Liver and pancreas [66],
glucose regulation, gene mutations
are associated with arterial tortuosity
syndrome [46].

Uncharacterized [78].

Conserved in chicken, dog,
cow, chimpanzee, frog, Rhesus
glut11/slc2a11
monkey and zebrafish and
frog. Orthologs found in 111
organisms [46].

Glucose, fructose. 11-A: skeletal
muscle, heart, kidney. 11-B: adipose
tissue, kidney, placenta. 11-C: skeletal
muscle, heart, adipose tissue,
pancreas [62], 11-D [46].

Uncharacterized [78].

Conserved in chicken, dog,
mouse, rat, chimpanzee,
Rhesus monkey, cow, frog,
zebrafish, rice and A. thaliana.
Orthologs found in 177
organisms [46].

GLUT8/GLUT12 [46], skeletal muscle,
heart, prostate, lower levels in brain,
placenta, kidneys [69], wide variety
of hexoses [68],
Alzheimer’s, hypertension,
diabetic neuropathy [71].

Insulin-sensitive. May
act as GLUT4 in skeletal
and cardiac muscle [72].

Conserved in chicken, dog,
cow, chimpanzee, rice, Rhesus
monkey, mouse, rat, frog,
zebrafish, C. elegans,
glut13/slc2a13
S. cerevisiae, K. lactis, E. gossypii,
Schizosaccharomyces pombe and
A. thaliana. Orthologs found in
151 organisms [46].

Glial cells and neurons [73],
myo-inositol and related
stereoisomers [74], non-small-cell
lung cancer [75], Parkinson’s [76].

Uncharacterized.

2 organisms have orthologs of
human slc2a14 [46].

Spermatogenesis [46], Alzheimer’s
disease [47],
gastric adenocarcinoma [48].

N/A

glut12/slc2a12

glut14/slc2a14

Orthologs

A study from 1994 showed GLUT2 to be predominantly expressed in the chicken liver, but absent
in the chicken brain and heart. Similar to mammalian species, this early study revealed how
multiple GLUTs coexisted in various tissues in chickens. A 2001 study examined chicken mRNA
and protein expression during different stages of embryonic development. GLUT1, GLUT3 and
GLUT4 were examined in several tissues during embryogenesis. In the chicken brain, GLUT1 mRNA
levels were high throughout development, although GLUT1 protein expression was highest during
early development. GLUT3 mRNA expression in the brain was highest during the last half of
development, with high protein expression very early and very late in development. In skeletal
muscle, mRNA and protein expression of GLUT1 and GLUT3 were high during early development,
but decreased by mid-development. GLUT1 mRNA and protein expression were also highest during
early development, then declined steadily throughout development. GLUT1 mRNA levels were high
in the liver, but protein expression of GLUT1 was not detectable. This study determined that GLUT1
is developmentally regulated in the chicken brain, heart and skeletal muscle. GLUT3 in the brain
increased throughout the stages of development, but was absent in skeletal muscle. This study also
revealed that GLUT4 was absent in chicken heart and skeletal muscle [80].
Because GLUT4 homologs were found to be lacking in chickens, GLUT8, an insulin-responsive
GLUT in mammalian blastocytes [81], was tested across various chicken tissues. In 2003, a research
team used reverse transcription polymerase chain reaction (RT-PCR), DNA sequencing and Northern
and Southern blot analysis to identify GLUT8 mRNA expression in different chicken tissues. GLUT8
mRNA expression was barely detectable in chicken adipose tissue, liver, heart and skeletal muscle.
This study revealed that GLUT8 mRNA expression was different from mammalian species, in which
GLUT8 is expressed across most insulin-responsive tissues [2].
In a 2005 follow up study by the same team of researchers, GLUT1, GLUT2, GLUT3 and GLUT8 were
examined for the extent of mRNA expression across different chicken tissues, this time using real-time
quantitative polymerase chain reaction (RT-qPCR) with SYBR Green I fluorescence. In this study, GLUT1
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mRNA expression was detected across most of the tissues examined, with highest concentrations in
adipose tissue and brain. GLUT2 mRNA expression was detectable only in the liver and kidneys. GLUT3
was found to be highly expressed in the brain, and GLUT8 mRNA was ubiquitously expressed across all
chicken tissues with higher expression in adipose tissue and kidneys [1].
A 2014 study found that high bodyweight chickens are generally compulsive feeders with a different
food intake and blood glucose threshold sensitivity to insulin [82]. In this study, GLUTs were expressed
differently across insulin-induced hypoglycemic high versus low bodyweight chickens. Expression of
GLUT1, GLUT2 and GLUT3 mRNA was higher in the hypothalamus and liver across high bodyweight
groups. Hypoglycemia in chickens correlated with reduced GLUT expression in the liver [82].
Relative comparison methods were used for comparing GLUT mRNA expression across different
genes. Our laboratory has developed an absolute quantification protocol to study a panel of different
GLUTs across multiple chicken tissues. The absolute quantification method has allowed us to
compare mRNA levels across different GLUTs (i.e., GLUT1 compared to GLUT2) and different tissues.
By calculating absolute copy number values for absolute quantification, we were able to compare GLUT
mRNA expression patterns across a tissue panel of different GLUTs. Results showed that the mRNA
levels of different GLUTs have clear tissue specificity; many GLUTs are expressed in the same tissues.
With sequence analysis and RT-qPCR, we have also found new glut genes in chickens, including a
member very similar to human glut9 and several members similar to mammalian glut11. Analysis of
these paralogs revealed their distinct expression pattern.
7. Prospects and Conclusions
As is the case for many protein families containing multiple paralogs in a species, the GLUT family
of proteins exerts essential physiological functions that need be delicately regulated. Multiple proteins
with overlapping molecular functions provide a cushion for genetic, physiological and environmental
disturbance. At the same time, tissue specific distribution of these transporters allows the fine tuning
of expression to the tissue specific condition. Studies on the details of this fine regulation have just
started. Much remains to be investigated. It would not be surprising if some day findings indicate
that a specific GLUT is a limiting factor to the development of a specific cell type. Physiological and
genomic evidence indicate that the regulation of glucose homeostasis in avians is distinct from the
mammalian counterpart. Further examination of GLUT members in birds will shed new light on the
function of these family.
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